News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
609,554 Results
Type
Article (22342)
Company Profile (207)
Press Release (587000)
Multimedia
Podcasts (34)
Webinars (19)
Section
Business (197483)
Career Advice (1341)
Deals (29883)
Drug Delivery (69)
Drug Development (65412)
Employer Resources (161)
FDA (12762)
Job Trends (11867)
News (286885)
Policy (23372)
Tag
2025 Best Places to Work (1)
2026 Best Places to Work (1)
2027 BioCapital Standard (4)
2027 BioMidwest Digital (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (3)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (5)
2027 Genetown Elite (5)
2027 Genetown Premier (1)
2027 Genetown Standard (8)
2027 Pharm Country Digital (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (10)
40 Under 40 (1)
Academia (1514)
Academic (1)
Accelerated approval (50)
ADA (34)
Adcomms (7)
Allergies (173)
Alliances (41734)
ALS (197)
Alzheimer's disease (1356)
Antibody-drug conjugate (ADC) (448)
Approvals (13636)
Artificial intelligence (699)
ASCO (222)
Autoimmune disease (346)
Automation (61)
Bankruptcy (286)
Belgium (18)
Best Places to Work (9351)
BIO (53)
Biologics (66)
BIOSECURE Act (9)
Biosimilars (167)
BioSpace Insights (115)
Biotechnology (117)
Bispecific (31)
Bladder cancer (183)
Brain cancer (53)
Breast cancer (686)
Cancer (5408)
Cardiovascular disease (375)
Career advice (1190)
Career pathing (47)
CAR-T (281)
CDC (9)
CDMO (93)
Celiac Disease (5)
Cell therapy (779)
Cervical cancer (55)
Clinical research (59919)
Collaboration (2000)
Commercialization (38)
Compensation (1662)
Complete response letters (51)
COVID-19 (1329)
CRISPR (112)
CRO (3)
C-suite (1240)
Cystic fibrosis (148)
Data (8532)
Decentralized trials (3)
Denatured (19)
Depression (153)
Dermatology (149)
Diabetes (571)
Diagnostics (5690)
Digital health (58)
Diversity (8)
Diversity, equity & inclusion (37)
Drug discovery (346)
Drug pricing (62)
Drug shortages (12)
Duchenne muscular dystrophy (250)
Earnings (80920)
Editorial (21)
Employer branding (25)
Employer resources (141)
ESMO (305)
Events (106660)
Executive appointments (1045)
Eye disease (11)
FDA (16806)
Fibrodysplasia Ossificans Progressiva (14)
Fragile X (5)
Friedreich's ataxia (23)
Frontotemporal dementia (31)
Funding (1715)
Gene editing (213)
Generative AI (57)
Gene therapy (608)
GLP-1 (562)
Government (2159)
Grass and pollen (2)
Guidances (357)
Healthcare (13759)
Hematology (143)
HIV (77)
Huntington's disease (58)
Idiopathic pulmonary fibrosis (11)
IgA nephropathy (109)
Immunology and inflammation (180)
Immuno-oncology (90)
Indications (241)
Infectious disease (1606)
Inflammatory bowel disease (206)
Inflation Reduction Act (8)
Influenza (112)
Intellectual property (314)
Interviews (215)
IPO (14205)
IRA (14)
Job creations (2798)
Job search strategy (1016)
JPM (20)
Kidney cancer (19)
Kidney disease (128)
Labor market (113)
Layoffs (206)
Leadership (29)
Legal (6032)
Licensing (70)
Liver cancer (71)
Longevity (41)
Lung cancer (745)
Lung diease (14)
Lymphoma (380)
Machine learning (54)
Management (53)
Manufacturing (1022)
Marketing (27)
MASH (150)
Medical affairs (3)
Medical device (11301)
Medtech (11550)
Mergers & acquisitions (17043)
Metabolic disorders (1150)
mRNA (137)
Multiple sclerosis (184)
Multispecific (4)
NASH (7)
Netherlands (20)
Neurodegenerative disease (359)
Neuropsychiatric disorders (68)
Neuroscience (2824)
Neurotech (3)
NextGen: Class of 2026 (4857)
Non-profit (3016)
Now hiring (88)
Obesity (400)
Opinion (173)
Ovarian cancer (223)
Pain (261)
Pancreatic cancer (296)
Parkinson's disease (334)
Partnered (32)
Patents (615)
Patient advocacy (4)
Patient recruitment (766)
Patient selection (63)
Peanut (67)
People (51393)
Peptides (23)
Pharmaceutical (48)
Pharmacy benefit managers (16)
Phase 1 (18806)
Phase 2 (26458)
Phase 3 (19112)
Pipeline (11079)
Policy (109)
Postmarket research (2051)
Preclinical (7937)
Press Release (69)
Prostate cancer (294)
Psychedelics (34)
Radioligand (1)
Radiopharmaceuticals (293)
Rare diseases (1071)
Real estate (4651)
Recruiting (65)
Regenerative medicine (16)
Regulatory (20255)
Reports (67)
Research institute (1524)
Resumes & cover letters (177)
Rett syndrome (53)
RNA editing (25)
RSV (63)
Schizophrenia (164)
Series A (306)
Series B (212)
Service/supplier (8)
Sickle cell disease (111)
Special edition (8)
Spinal muscular atrophy (146)
Sponsored (27)
Startups (3091)
State (1)
Stem cells (3)
Stomach cancer (4)
Substance use disorders (18)
Supply chain (89)
Switzerland (7)
Tariffs (16)
Tax incentives (1)
The Weekly (15)
Vaccines (593)
Venture capital (112)
Weight loss (172)
Wet AMD (7)
Women's health (134)
Worklife (25)
Date
Today (1)
Last 7 days (640)
Last 30 days (2263)
Last 365 days (25095)
2026 (20961)
2025 (25006)
2024 (29343)
2023 (33514)
2022 (42837)
2021 (46416)
2020 (42946)
2019 (34026)
2018 (25442)
2017 (25048)
2016 (24276)
2015 (30604)
2014 (26260)
2013 (22066)
2012 (24052)
2011 (24511)
2010 (23497)
Location
Africa (541)
Alabama (92)
Alaska (7)
Arizona (364)
Arkansas (15)
Asia (28152)
Australia (4272)
California (14738)
Canada (3903)
China (1054)
Colorado (657)
Connecticut (608)
Delaware (382)
Europe (56912)
Florida (2179)
Georgia (491)
Hawaii (5)
Idaho (53)
Illinois (1092)
India (105)
Indiana (620)
Iowa (31)
Japan (670)
Kansas (128)
Kentucky (43)
Louisiana (44)
Maine (37)
Maryland (1584)
Massachusetts (10377)
Michigan (356)
Minnesota (759)
Mississippi (8)
Missouri (112)
Montana (25)
Nebraska (16)
Nevada (156)
New Hampshire (71)
New Jersey (3696)
New Mexico (25)
New York (3708)
North Carolina (1774)
North Dakota (8)
Northern California (7549)
Ohio (440)
Oklahoma (20)
Oregon (38)
Pennsylvania (2731)
Puerto Rico (29)
Rhode Island (42)
South America (762)
South Carolina (91)
South Dakota (1)
Southern California (5991)
Tennessee (168)
Texas (2433)
United States (50351)
Utah (454)
Vermont (1)
Virginia (278)
Washington D.C. (67)
Washington State (1166)
West Virginia (3)
Wisconsin (145)
Wyoming (4)
609,554 Results for "life chemicals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lunai Bioworks (Nasdaq: LNAI) Demonstrates AI Chemical-Risk Screening for Generative AI
September 16, 2026
·
8 min read
Press Releases
HydRegen Raises $8M (£6M) Series A to Bring Biocatalysis to Industrial Chemical Manufacturing
October 14, 2026
·
4 min read
Press Releases
Mitsui Chemicals Launches InnoCell™ P-Type High Oxygen-Permeable Culture Plates to Accelerate Organoid-Based Drug Discovery
October 5, 2026
·
4 min read
Press Releases
Loop Chemicals Licenses Chemical Looping Ammonia Technology from Sandia National Laboratories
May 7, 2026
·
3 min read
Press Releases
American Chemical Society CRT | Model Medicines Publishes Class-Leading, Regulatory Grade Toxicology Model AmesNet™, Validation of GALILEO™ Platform & ChemPrint™ Model Underpinning Drug Pipeline
AmesNet’s Task-Conditioned Learning architecture outperforms FDA, MIT, Tencent, and the University of Sydney models in both sensitivity and balanced accuracy on out-of-domain chemical data on a public dataset; AmesNet is built on top of ChemPrint, the core and proprietary deep-learning engine of the GALILEO platform that powers the company’s drug pipeline.
June 30, 2026
·
1 min read
Funding
OrbiMed raises two new life sciences funds worth $3B with one aiming for Asia
The sixth cycle of OrbiMed’s Asia Partners fund included one with more than $1 billion earmarked for life science companies based on the Eastern continent.
October 16, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Chipscreen Biosciences Announced NMPA Approval of IND for CS43158, an AML Candidate Discovered via the AI-enabled Chemical Genomics Platform
October 12, 2026
·
3 min read
Press Releases
IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes
October 7, 2026
·
2 min read
Press Releases
Life Sciences BC 2026-27 Board Announcement
October 23, 2026
·
2 min read
Press Releases
Revel Pharmaceuticals and Collaborators Report Enzymatic Reversal of a Chemical Hallmark of Aging in Human Tissue
July 14, 2026
·
2 min read
1 of 60,956
Next
